患者处理：有复杂病史的跨性别成年人的激素治疗。
Approach to the Patient: Hormonal Therapy in Transgender Adults With Complex Medical Histories.
机构信息
Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO 80045, USA.
Endocrinology Service, Medicine Service, Rocky Mountain Regional Veterans Affairs Medical Center, Eastern Colorado Health Care System, Aurora, CO 80045, USA.
出版信息
J Clin Endocrinol Metab. 2024 Jan 18;109(2):592-602. doi: 10.1210/clinem/dgad536.
Abstract
While endocrinologists continue to initiate gender-affirming hormone therapy (GAHT) in healthy transgender and gender diverse (TGD) patients, they may also encounter more TGD patients in their clinics with complex medical histories that influence the patient-provider shared decision-making process for initiating or continuing GAHT. The purpose of this Approach to the Patient article is to describe management considerations in 2 adults with thromboembolic disease and 2 adults with low bone mineral density in the setting of feminizing and masculinizing GAHT.
摘要
虽然内分泌学家继续为健康的跨性别和性别多样化（TGD）患者启动性别肯定激素治疗（GAHT），但他们在诊所中也可能会遇到更多具有复杂病史的 TGD 患者，这些病史会影响启动或继续 GAHT 的医患共同决策过程。本文的目的是描述在接受女性化和男性化 GAHT 治疗的 2 例血栓栓塞性疾病患者和 2 例低骨密度患者的管理注意事项。
相似文献
1
Approach to the Patient: Hormonal Therapy in Transgender Adults With Complex Medical Histories.患者处理：有复杂病史的跨性别成年人的激素治疗。
J Clin Endocrinol Metab. 2024 Jan 18;109(2):592-602. doi: 10.1210/clinem/dgad536.
2
Clinicians in the Veterans Health Administration initiate gender-affirming hormone therapy in concordance with clinical guideline recommendations.退伍军人健康管理局的临床医生根据临床指南建议启动性别肯定激素治疗。
Front Endocrinol (Lausanne). 2024 May 10;15:1086158. doi: 10.3389/fendo.2024.1086158. eCollection 2024.
3
Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risks.跨性别和性别多样化人群的性别肯定激素治疗：治疗方式、监测和风险概述。
Neurourol Urodyn. 2023 Jun;42(5):903-920. doi: 10.1002/nau.25097. Epub 2022 Nov 20.
4
Bone health in transgender assigned female at birth people: effects of gender-affirming hormone therapy and gonadectomy.出生时被指定为女性的跨性别者的骨骼健康：性别肯定激素治疗和性腺切除术的影响。
Front Endocrinol (Lausanne). 2024 Sep 26;15:1416121. doi: 10.3389/fendo.2024.1416121. eCollection 2024.
5
Barriers and Facilitators to Gender-affirming Hormone Therapy in the Veterans Health Administration.退伍军人事务部中性别肯定激素治疗的障碍和促进因素。
Ann Behav Med. 2023 Nov 16;57(12):1014-1023. doi: 10.1093/abm/kaad035.
6
Routine Screening for Transgender and Gender Diverse Adults Taking Gender-Affirming Hormone Therapy: a Narrative Review.常规筛查接受性别肯定激素治疗的跨性别和性别多样化成年人：一项叙述性综述。
J Gen Intern Med. 2021 May;36(5):1380-1389. doi: 10.1007/s11606-021-06634-7. Epub 2021 Feb 5.
7
Transgender patients and gender-affirming hormone therapy through the mid-life.中年跨性别患者与性别确认激素疗法
Maturitas. 2024 Nov;189:108093. doi: 10.1016/j.maturitas.2024.108093. Epub 2024 Aug 20.
8
Transgender health and the impact of aging and menopause.跨性别者健康与衰老和绝经的影响。
Climacteric. 2023 Jun;26(3):256-262. doi: 10.1080/13697137.2023.2176217. Epub 2023 Apr 3.
9
Androgenetic alopecia incidence in transgender and gender diverse populations: A retrospective comparative cohort study.雄激素性脱发在跨性别和性别多样化人群中的发病率：一项回顾性对比队列研究。
J Am Acad Dermatol. 2023 Sep;89(3):504-510. doi: 10.1016/j.jaad.2023.01.037. Epub 2023 Feb 11.
10
Breast care considerations for transgender and gender-diverse patients.跨性别和性别多样化患者的乳房保健注意事项。
Womens Health (Lond). 2024 Jan-Dec;20:17455057241289706. doi: 10.1177/17455057241289706.
引用本文的文献
1
Osteosarcopenia in older adults undergoing transcatheter aortic valve replacement: A narrative review of mortality and frailty implications.接受经导管主动脉瓣置换术的老年人中的骨质肌肉减少症：关于死亡率和衰弱影响的叙述性综述
World J Cardiol. 2025 May 26;17(5):107320. doi: 10.4330/wjc.v17.i5.107320.
2
Recent insights into the role of hormones during development and their functional regulation.近期关于激素在发育过程中的作用及其功能调节的见解。
Front Endocrinol (Lausanne). 2024 Jan 22;15:1340432. doi: 10.3389/fendo.2024.1340432. eCollection 2024.
本文引用的文献
1
Cardiovascular Safety of Testosterone-Replacement Therapy.睾酮替代疗法的心血管安全性。
N Engl J Med. 2023 Jul 13;389(2):107-117. doi: 10.1056/NEJMoa2215025. Epub 2023 Jun 16.
2
Comparison of the Subcutaneous and Intramuscular Estradiol Regimens as Part of Gender-Affirming Hormone Therapy.皮下和肌内雌二醇方案在性别肯定激素治疗中的比较。
Endocr Pract. 2023 May;29(5):356-361. doi: 10.1016/j.eprac.2023.02.006. Epub 2023 Mar 1.
3
Thrombophilia and hormonal therapy in transgender persons: A literature review and case series.易性症患者的血栓形成倾向与激素治疗：文献综述及病例系列
Int J Transgend Health. 2022 Jan 20;23(4):377-391. doi: 10.1080/26895269.2022.2025551. eCollection 2022.
4
The Utility of Monitoring Potassium in Transgender, Gender Diverse, and Nonbinary Individuals on Spironolactone.监测服用螺内酯的跨性别者、性别多样化者和非二元性别者血钾的效用
J Endocr Soc. 2022 Sep 12;6(11):bvac133. doi: 10.1210/jendso/bvac133. eCollection 2022 Oct 11.
5
Standards of Care for the Health of Transgender and Gender Diverse People, Version 8.《跨性别和性别多样化人群健康照护标准》第8版
Int J Transgend Health. 2022 Sep 6;23(Suppl 1):S1-S259. doi: 10.1080/26895269.2022.2100644. eCollection 2022.
6
Hematologic concerns in transgender patients.transgender患者的血液学问题。
Clin Adv Hematol Oncol. 2022 Aug;20(8):516-523.
7
Progestogen Use in Gender-Affirming Hormone Therapy: A Systematic Review.孕激素在性别确认激素治疗中的应用：一项系统评价。
Endocr Pract. 2022 Dec;28(12):1244-1252. doi: 10.1016/j.eprac.2022.08.012. Epub 2022 Aug 23.
8
Osteoporosis and Bone Health in Transgender Individuals.跨性别者的骨质疏松症和骨骼健康。
Calcif Tissue Int. 2022 May;110(5):615-623. doi: 10.1007/s00223-022-00972-2. Epub 2022 Apr 2.
9
Bone Microarchitecture in Transgender Adults: A Cross-Sectional Study.成年跨性别者的骨微结构：一项横断面研究。
J Bone Miner Res. 2022 Apr;37(4):643-648. doi: 10.1002/jbmr.4497. Epub 2022 Jan 22.
10
Bone mineral density, trabecular bone score and muscle strength in transgender men receiving testosterone therapy versus cisgender men. transgender 男性接受睾丸素治疗与 cisgender 男性的骨密度、骨小梁评分和肌肉力量。
Steroids. 2022 Feb;178:108951. doi: 10.1016/j.steroids.2021.108951. Epub 2021 Dec 23.
Zotero 插件